Your browser doesn't support javascript.
loading
Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience.
Lee Chuy, Katherine; Oikonomou, Evangelos K; Postow, Michael A; Callahan, Margaret K; Chapman, Paul B; Shoushtari, Alexander N; Neilan, Tomas G; Fradley, Michael G; Ramanathan, Lakshmi V; Wolchok, Jedd D; Steingart, Richard M; Gupta, Dipti.
Afiliação
  • Lee Chuy K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Oikonomou EK; The Queen's College, University of Oxford, Oxford, United Kingdom.
  • Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Callahan MK; Weill Cornell Medical College, New York, New York, USA.
  • Chapman PB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shoushtari AN; Weill Cornell Medical College, New York, New York, USA.
  • Neilan TG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Fradley MG; Weill Cornell Medical College, New York, New York, USA.
  • Ramanathan LV; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Wolchok JD; Weill Cornell Medical College, New York, New York, USA.
  • Steingart RM; Cardio-Oncology Program, Division of Cardiology, Department of Medicine and Cardiac MR PET CT Program, Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gupta D; Cardio-Oncology Program, H. Lee Moffitt Cancer Center & Research Institute and University of South Florida Division of Cardiovascular Medicine, Tampa, Florida, USA.
Oncologist ; 24(5): e196-e197, 2019 05.
Article em En | MEDLINE | ID: mdl-30910868
ABSTRACT
This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Melanoma / Miocardite Tipo de estudo: Etiology_studies / Screening_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Melanoma / Miocardite Tipo de estudo: Etiology_studies / Screening_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos